We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Oncologic Safety of Laparoscopic Rectal Cancer Surgery Is Dubious

By HospiMedica International staff writers
Posted on 22 Feb 2017
Print article
Patients undergoing laparoscopic rectal resection (LRR) have increased risk for incomplete tumor excision compared to open surgery, according to a new study.

Researchers at Henri Mondor University Hospital, Hospital Universitario Doctor Peset, and Rothschild Hospital conducted a meta-analysis of studies to examine the evidence concerning the pathologic outcomes of LRR versus open rectal resection (ORR) for rectal cancer. Of 369 records screened, 14 RCTs were selected for the qualitative and quantitative analyses. Main outcomes and measures included rate of positive circumferential resection margin (CRM) and the quality of mesorectal excision.

The researchers identified a positive CRM in 7.9% and 6.1% percent of patients undergoing LRR and ORR, respectively. In five studies, a noncomplete mesorectal excision occurred in 13.2% and 10.4% of LRR and ORR patients, respectively. There was no significant difference between LRR and ORR in the distal resection margin involvement, the mean number of lymph nodes retrieved, mean distance to the distal margin, and the mean distance to radial margins. The study was published on February 8, 2017, in JAMA Surgery.

“Based on the available evidence, the risk for achieving noncomplete mesorectal excision is significantly higher in patients undergoing LRR, compared with ORR,” concluded lead author Aleix Martínez-Pérez, MD, of Henri Mondor University Hospital, and colleagues. “These findings question the oncologic safety of laparoscopy for the treatment of rectal cancer. However, long-term results of the ongoing RCTs are awaited to assess whether these pathologic results have an effect on disease-free and overall patient survival.”

Total mesorectal excision is used in the treatment of colorectal cancer, during which a significant length of the bowel around the tumor is removed. It involves a low anterior resection for tumors of the middle and the lower rectum, wherein it is essential to remove the rectum along with the mesorectum up to the level of the levators.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Aortic Valve Replacement System
INTUITY Elite
New
Rapid Cleaning Verification Tool
ProExpose Protein Detection Test

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.